Compare Boeing Co (BA) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boeing Co vs GeneDx Holdings Corp — how do they compare? Boeing Co trades at $233.4 (market cap $184.35B), while GeneDx Holdings Corp trades at $81.66 (market cap $2.44B). The key difference: Boeing Co is far larger — about 75.6× GeneDx Holdings Corp's market cap, and Boeing Co pays a 0.03% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| BA | WGS | |
|---|---|---|
Market Cap | $184.35B | $2.44B |
Volume | 7,591,579 | — |
Sector | Industrials | Technology |
52-Week High | $252.15 | $167.51 |
52-Week Low | $179.12 | $34.51 |
Enterprise Value | $210.23B | $2.48B |
Dividend Yield | 0.03% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boeing Co
The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.
Read more on BA →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
